Olmesartan Medoxomil
Rank #322 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$33.8M
Total Cost
1,102,412
Total Claims
$33.8M
Total Cost
30,637
Prescribers
$31
Cost per Claim
203,682
Beneficiaries
2,725,124
30-Day Fills
$1,104
Avg Cost/Provider
36
Avg Claims/Provider
Share of Medicare Part D Spending
0.01%
of total Medicare Part D spending
$33.8M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $33.8M total
Top Prescribers of Olmesartan Medoxomil
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Raul Rivera | Internal Medicine | Pasadena, TX | 854 | $46K |
| 2 | Afshine Emrani | Cardiology | Tarzana, CA | 831 | $37K |
| 3 | Kelvin Mai | Internal Medicine | Santa Ana, CA | 1,104 | $37K |
| 4 | Luis Gonzalez | Cardiology | West New York, NJ | 337 | $36K |
| 5 | Nina Kushner | Internal Medicine | Brooklyn, NY | 56 | $36K |
| 6 | Tai Wu | Internal Medicine | San Gabriel, CA | 1,115 | $32K |
| 7 | Manuel Aguilera | Internal Medicine | Carson, CA | 752 | $31K |
| 8 | Mohammad Chaudhry | Internal Medicine | Union City, NJ | 246 | $31K |
| 9 | Gerald Mancuso | Cardiology | Kansas City, MO | 976 | $30K |
| 10 | Henry Yee | Cardiology | Alhambra, CA | 723 | $29K |
| 11 | Marina Kovalevsky | Internal Medicine | Los Angeles, CA | 48 | $29K |
| 12 | Jae Yoo | Internal Medicine | Los Angeles, CA | 923 | $28K |
| 13 | Edward Carlos | Internal Medicine | Mobile, AL | 1,037 | $27K |
| 14 | Gary Reznik | Cardiology | Los Angeles, CA | 1,058 | $27K |
| 15 | Chinh Huynh | General Practice | Westminster, CA | 514 | $26K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 319 | Clonazepam (Clonazepam) | $34.4M | 3,685,968 |
| 320 | Tolvaptan (Jynarque) | $34.4M | 2,760 |
| 321 | Dalfampridine (Dalfampridine Er) | $34.1M | 40,425 |
| 322 | Olmesartan Medoxomil (Olmesartan Medoxomil) | $33.8M | 1,102,412 |
| 323 | Niraparib Tosylate (Zejula) | $33.7M | 2,206 |
| 324 | Tapentadol Hcl (Nucynta) | $33.6M | 29,886 |
| 325 | Dorzolamide Hcl/Timolol Maleat (Dorzolamide-Timolol) | $33.5M | 1,096,480 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology